A	O
remote	O
GATA2	O
hematopoietic	O
enhancer	O
drives	O
leukemogenesis	O
in	O
inv	O
(	O
3	O
)	O
(	O
q21	O
;	O
q26	O
)	O
by	O
activating	O
EVI1	O
expression	O
.	O


Chromosomal	O
inversion	O
between	O
3q21	O
and	O
3q26	O
results	O
in	O
high	O
-	O
risk	O
acute	O
myeloid	O
leukemia	O
(	O
AML	O
)	O
.	O


In	O
this	O
study	O
,	O
we	O
identified	O
a	O
mechanism	O
whereby	O
a	O
GATA2	O
distal	O
hematopoietic	O
enhancer	O
(	O
G2DHE	O
or	O
-	O
77	O
-	O
kb	O
enhancer	O
)	O
is	O
brought	O
into	O
close	O
proximity	O
to	O
the	O
EVI1	O
gene	O
in	O
inv	O
(	O
3	O
)	O
(	O
q21	O
;	O
q26	O
)	O
inversions	O
,	O
leading	O
to	O
leukemogenesis	O
.	O


We	O
examined	O
the	O
contribution	O
of	O
G2DHE	O
to	O
leukemogenesis	O
by	O
creating	O
a	O
bacterial	O
artificial	O
chromosome	O
(	O
BAC	O
)	O
transgenic	O
model	O
that	O
recapitulates	O
the	O
inv	O
(	O
3	O
)	O
(	O
q21	O
;	O
q26	O
)	O
allele	O
.	O


Transgenic	O
mice	O
harboring	O
a	O
linked	O
BAC	O
developed	O
leukemia	O
accompanied	O
by	O
EVI1	O
overexpression	O
-	O
neoplasia	O
that	O
was	O
not	O
detected	O
in	O
mice	O
bearing	O
the	O
same	O
transgene	O
but	O
that	O
was	O
missing	O
the	O
GATA2	O
enhancer	O
.	O


These	O
results	O
establish	O
the	O
mechanistic	O
basis	O
underlying	O
the	O
pathogenesis	O
of	O
a	O
severe	O
form	O
of	O
leukemia	O
through	O
aberrant	O
expression	O
of	O
the	O
EVI1	O
proto	O
-	O
oncogene	O
.	O
